Ferroptosis Induction in Multiple Myeloma Cells Triggers DNA Methylation and Histone Modification Changes Associated with Cellular Senescence
Disease relapse and therapy resistance remain key challenges in treating multiple myeloma. Underlying (epi-)mutational events can promote myelomagenesis and contribute to multi-drug and apoptosis resistance. Therefore, compounds inducing ferroptosis, a form of iron and lipid peroxidation-regulated c...
Saved in:
Main Authors: | Emilie Logie, Bart Van Puyvelde, Bart Cuypers, Anne Schepers, Herald Berghmans, Jelle Verdonck, Kris Laukens, Lode Godderis, Maarten Dhaenens, Dieter Deforce, Wim Vanden Berghe |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/128c5ee5fc334f36a213008aab24613c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
by: Jacob King, et al.
Published: (2021) -
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
by: Tandon N, et al.
Published: (2016) -
An Emerging Role for Epigenetics in Cerebral Palsy
by: Brigette Romero, et al.
Published: (2021) -
Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer
by: Norikazu Masuda, et al.
Published: (2021) -
Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells
by: Xuemei Yao, et al.
Published: (2021)